In contrast to our findings with GFAP expression, we found a significant increase in Iba-1 expression with elevated levels in the DG of TgF344-AD rats compared to WT, but this was specific to TMG-treated groups, with no significant differences in Iba-1 expression in the saline-treated groups. Here, GFAP is linked to Alzheimer disease.